Product NDC: | 13537-123 |
Proprietary Name: | CYZONE |
Non Proprietary Name: | Octinoxate and Titanium Dioxide |
Active Ingredient(s): | .06; .008 g/g; g/g & nbsp; Octinoxate and Titanium Dioxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-123 |
Labeler Name: | Ventura Corporation Ltd. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20111213 |
Package NDC: | 13537-123-01 |
Package Description: | 1 TUBE in 1 BAG (13537-123-01) > 27 g in 1 TUBE |
NDC Code | 13537-123-01 |
Proprietary Name | CYZONE |
Package Description | 1 TUBE in 1 BAG (13537-123-01) > 27 g in 1 TUBE |
Product NDC | 13537-123 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Octinoxate and Titanium Dioxide |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20111213 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura Corporation Ltd. |
Substance Name | OCTINOXATE; TITANIUM DIOXIDE |
Strength Number | .06; .008 |
Strength Unit | g/g; g/g |
Pharmaceutical Classes |